Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 11, 2024 |
| PDB ID | UniProt ID ▲ | Title | Descriptor |
|---|---|---|---|
| 7SXZ | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement) | |
| 7V26 | P0DTC2 | XG005-bound SARS-CoV-2 S | |
| 7V2A | P0DTC2 | SARS-CoV-2 Spike trimer in complex with XG014 Fab | |
| 7V7R | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 4 | |
| 7V81 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
| 7Z0X | P0DTC2 | THSC20.HVTR26 Fab bound to SARS-CoV-2 Receptor Binding Domain | |
| 7Z0Y | P0DTC2 | THSC20.HVTR04 Fab bound to SARS-CoV-2 Receptor Binding Domain | |
| 7TEW | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
| 7EJY | P0DTC2 | Complex Structure of antibody BD-503 and RBD of COVID-19 | |
| 7EJZ | P0DTC2 | Complex Structure of antibody BD-503 and RBD-S477N of COVID-19 | |
| 7FJO | P0DTC2 | Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with three T6 Fab | |
| 8WZI | P0DTC2 | One RBD up state of Spike glycoprotein, SARS-CoV-2 | |
| 8XKI | P0DTC2 | A neutralizing nanobody VHH60 against wt SARS-CoV-2 | |
| 7QUR | P0DTC2 | SARS-CoV-2 Spike with ethylbenzamide-tri-iodo Siallyllactose, C3 symmetry | |
| 7WHH | P0DTC2 | Crystal structure of SARS-CoV-2 omicron RBD and human ACE2 | |
| 7WS0 | P0DTC2 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
| 7WS1 | P0DTC2 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
| 7WS3 | P0DTC2 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
| 7WS4 | P0DTC2 | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
| 7WS5 | P0DTC2 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
| 7WS7 | P0DTC2 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
| 7WS8 | P0DTC2 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
| 7WS9 | P0DTC2 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
| 7WSA | P0DTC2 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
| 7WWL | P0DTC2 | S protein of Delta variant in complex with ZWD12 | |
| 7WWM | P0DTC2 | S protein of Delta variant in complex with ZWC6 | |
| 7ZF7 | P0DTC2 | SARS-CoV-2 Omicron BA.2 RBD in complex with ACE2 | |
| 7ZF9 | P0DTC2 | SARS-CoV-2 Omicron BA.2 RBD in complex with COVOX-150 Fab (P21) | |
| 7ZFB | P0DTC2 | SARS-CoV-2 Omicron RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs | |
| 7ZFC | P0DTC2 | SARS-CoV-2 Beta RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs | |
| 7ZR7 | P0DTC2 | OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN | |
| 7ZR8 | P0DTC2 | OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement) | |
| 7ZR9 | P0DTC2 | OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN | |
| 7ZRC | P0DTC2 | OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE | |
| 7QUS | P0DTC2 | SARS-CoV-2 Spike, C3 symmetry | |
| 7R4I | P0DTC2 | The SARS-CoV-2 spike in complex with the 2.15 neutralizing nanobody | |
| 7R4Q | P0DTC2 | The SARS-CoV-2 spike in complex with the 1.29 neutralizing nanobody | |
| 7R4R | P0DTC2 | The SARS-CoV-2 spike in complex with the 1.10 neutralizing nanobody | |
| 7UHB | P0DTC2 | SARS-CoV-2 spike in complex with AHB2-2GS-SB175 (local refinement of the RBD and AHB2) | |
| 7UHC | P0DTC2 | SARS-CoV-2 spike in complex with AHB2-2GS-SB175 | |
| 7W6U | P0DTC2 | Structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor equine ACE2 | |
| 7WRI | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with mouse ACE2 | |
| 7WSK | P0DTC2 | Crystal structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with civet ACE2 | |
| 7XBY | P0DTC2 | The crystal structure of SARS-CoV-2 Omicron BA.1 variant RBD in complex with equine ACE2 | |
| 7ZXU | P0DTC2 | SARS-CoV-2 Omicron BA.4/5 RBD in complex with Beta-27 Fab and C1 nanobody | |
| 8VYE | P0DTC2 | SARS-CoV-2 S (C.37 Lambda variant) plus S309, S2L20, and S2X303 Fabs | |
| 8VYF | P0DTC2 | SARS-CoV-2 S NTD (C.37 Lambda variant) plus S2L20 and S2X303 Fabs, local refinement | |
| 8VYG | P0DTC2 | SARS-CoV-2 S RBD (C.37 Lambda variant) plus S309 Fab, local refinement | |
| 8WLO | P0DTC2 | Cryo-EM structure of SARS-CoV-2 prototype spike protein in complex with hippopotamus ACE2 | |
| 8WLR | P0DTC2 | Cryo-EM structure of SARS-CoV-2 prototype spike protein receptor-binding domain in complex with hippopotamus ACE2 |
